State WI
Clinical Trials in Wisconsin
Recruiting clinical trials with at least one study location in Wisconsin. Data updated daily from ClinicalTrials.gov.
Top Conditions in Wisconsin
NCT07227051 N/A
Recruiting
Optimizing Self-Monitoring Feedback Delivery for the Treatment of Overweight and...
Condition
Obesity & Overweight
Enrollment
300 pts
Location
United States
Sponsor
Wake Forest University Health
NCT05855200 Phase 3
Recruiting
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage ...
Condition
Colonic Neoplasms
Enrollment
892 pts
Location
United States, Argentina, Australia
Sponsor
GlaxoSmithKline
NCT06131801 N/A
Recruiting
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solutio...
Condition
Hematologic Malignancy
Enrollment
30 pts
Location
United States
Sponsor
Children's Hospital Medical Ce
NCT06662786 Phase 3
Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or ...
Condition
Colorectal Neoplasms
Enrollment
1,000 pts
Location
United States, Belgium, Brazil
Sponsor
Janssen Research & Development
NCT06494072 Phase 4
Recruiting
Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for ...
Condition
Community Acquired Pneumonia in Children
Enrollment
236 pts
Location
United States
Sponsor
Medical College of Wisconsin
NCT05458674 Phase 2
Recruiting
Tucatinib+Trastuzumab+Eribulin in HER2+ MBC
Condition
Breast Cancer
Enrollment
30 pts
Location
United States
Sponsor
Criterium, Inc.
NCT03547973 Phase 2
Recruiting
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Canno...
Condition
Metastatic Urothelial Cancer
Enrollment
827 pts
Location
United States, France, Germany
Sponsor
Gilead Sciences
NCT07435194 Phase 1
Recruiting
A Clinical Trial in Healthy Participants to Learn How Itraconazole Affects MK-28...
Condition
Healthy
Enrollment
28 pts
Location
United States
Sponsor
Merck Sharp & Dohme LLC
NCT01804686 Phase 3
Recruiting
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Condition
Chronic Lymphocytic Leukemia
Enrollment
700 pts
Location
United States, Argentina, Australia
Sponsor
Janssen Research & Development
NCT07441694 Phase 1
Recruiting
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Condition
Myeloproliferative Neoplasms
Enrollment
218 pts
Location
United States, Australia, Belgium
Sponsor
Incyte Corporation
NCT06616272 N/A
Recruiting
Cervical Spine Focused Treatment for Patients With Persistent Concussion Symptom...
Condition
Brain Concussion
Enrollment
40 pts
Location
United States, Ireland, United Kingdom
Sponsor
University of Pittsburgh
NCT06465810 N/A
Recruiting
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Condition
Transthyretin Amyloidosis
Enrollment
1,850 pts
Location
United States, Canada, China
Sponsor
AstraZeneca
NCT06422923 Phase 1, Phase 2
Recruiting
A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral...
Condition
Epilepsy, Temporal Lobe
Enrollment
10 pts
Location
United States
Sponsor
Neurona Therapeutics
NCT04293562 Phase 3
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilterit...
Condition
Acute Myeloid Leukemia
Enrollment
1,186 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT05243797 Phase 3
Recruiting
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Al...
Condition
Multiple Myeloma
Enrollment
1,594 pts
Location
United States, Argentina, Australia
Sponsor
European Myeloma Network B.V.
NCT05040360 Phase 2
Recruiting
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendo...
Condition
Metastatic Malignant Neoplasm in the Liver
Enrollment
141 pts
Location
United States, Mexico, Uruguay
Sponsor
SWOG Cancer Research Network
NCT04808323 Phase 1
Recruiting
MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer
Condition
Rectal Adenocarcinoma
Enrollment
22 pts
Location
United States
Sponsor
Medical College of Wisconsin
NCT06149286 Phase 3
Recruiting
A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works...
Condition
Relapsed/Refractory Follicular Lymphoma
Enrollment
470 pts
Location
United States, Australia, Austria
Sponsor
Regeneron Pharmaceuticals
NCT07283939 N/A
Recruiting
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned...
Condition
Ampulla of Vater Carcinoma
Enrollment
420 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT05633654 Phase 3
Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physic...
Condition
Triple Negative Breast Cancer
Enrollment
1,514 pts
Location
United States, Australia, France
Sponsor
Gilead Sciences
NCT06295367 N/A
Recruiting
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
Condition
Malignant Solid Neoplasm
Enrollment
760 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT06370520 N/A
Recruiting
Screening Emotions in Adolescents at the Hospital for mTBI
Condition
Brain Injury Traumatic Mild
Enrollment
2,592 pts
Location
United States
Sponsor
University of California, Davi
NCT07413900 N/A
Recruiting
Biomarkers Study in Infants With Prior Neonatal Brain Injury
Condition
HIE - Hypoxic - Ischemic Encephalopathy
Enrollment
100 pts
Location
United States
Sponsor
University of Wisconsin, Madis
NCT06441422 N/A
Recruiting
Blood Flow Restriction Training for People With Disabilities
Condition
Weakness, Muscle
Enrollment
24 pts
Location
United States
Sponsor
Medical College of Wisconsin
NCT06856577 Phase 3
Recruiting
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants ...
Condition
Neovascular Age-Related Macular Degeneration (nAMD)
Enrollment
284 pts
Location
United States
Sponsor
Adverum Biotechnologies, Inc.